PHASE-II TRIAL DESIGN CONSIDERATIONS FOR SMALL-CELL LUNG-CANCER

被引：23

作者：

MOORE, TD

KORN, EL

机构：

[1] NCI,DIV CANC TREATMENT,BIOMETR RES BRANCH,CANC THERAPY EVALUAT PROGRAM,EPN-739,BETHESDA,MD 20892

[2] NCI,CLIN INVEST BRANCH,BETHESDA,MD 20892

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1992年 / 84卷 / 03期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1093/jnci/84.3.150

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：150 / 154

页数：5

共 41 条

[1]

AISNER J, 1983, CANCER TREAT REP, V67, P37

[2]

AISNER J, 1987, CANCER TREAT REP, V71, P1131

[3]

AISNER J, 1989, SEMIN ONCOL, V16, P2

[4] SMALL-CELL CARCINOMA OF LUNG - REINDUCTION THERAPY AFTER LATE RELAPSE [J].

BATIST, G ;

IHDE, DC ;

ZABELL, A ;

LICHTER, AS ;

VEACH, SR ;

COHEN, MH ;

CARNEY, DN ;

BUNN, PA .

ANNALS OF INTERNAL MEDICINE, 1983, 98 (04) :472-474

[5] EPIRUBICIN IN EXTENSIVE SMALL-CELL LUNG-CANCER - A PHASE-II STUDY IN PREVIOUSLY UNTREATED PATIENTS - A NATIONAL CANCER INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY [J].

BLACKSTEIN, M ;

EISENHAUER, EA ;

WIERZBICKI, R ;

YOSHIDA, S .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :385-389

[6] TENIPOSIDE (VM-26), AN OVERLOOKED HIGHLY-ACTIVE AGENT IN SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II TRIAL IN UNTREATED PATIENTS [J].

BORK, E ;

HANSEN, M ;

DOMBERNOWSKY, P ;

HANSEN, SW ;

PEDERSEN, AG ;

HANSEN, HH .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :524-527

[7] TREATMENT OF BRONCHOGENIC CARCINOMA .2. SMALL CELL [J].

BRODER, LE ;

COHEN, MH ;

SELAWRY, OS .

CANCER TREATMENT REVIEWS, 1977, 4 (04) :219-260

[8]

BUNN PA, 1977, CANCER TREAT REP, V61, P333

[9]

CARNEY DN, 1983, CANCER TREAT REP, V67, P27

[10] UNEXPECTED HIGH TOXICITY IN A PHASE-II STUDY OF TENIPOSIDE (VM-26) IN ELDERLY PATIENTS WITH UNTREATED SMALL CELL LUNG-CANCER (SCLC) [J].

CERNY, T ;

PEDRAZZINI, A ;

JOSS, RA ;

BRUNNER, KW .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (11) :1791-1794

← 1 2 3 4 5 →